2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Weighted Average Number Of Diluted Shares Outstanding | 412.00 | 419.00 | 426.00 | NA | 434.00 | 431.00 | 430.00 | NA | 395.00 | 381.00 | 353.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Weighted Average Number Of Shares Outstanding Basic | 390.00 | 396.00 | 402.00 | NA | 404.00 | 402.00 | 400.00 | NA | 395.00 | 381.00 | 353.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Earnings Per Share Basic | 2.67 | 5.55 | 9.09 | 12.06 | 8.27 | 6.93 | 3.05 | -0.70 | -0.59 | -0.31 | -0.35 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Earnings Per Share Diluted | 2.53 | 5.24 | 8.58 | 11.29 | 7.70 | 6.46 | 2.84 | -0.70 | -0.59 | -0.31 | -0.35 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue From Contract With Customer Excluding Assessed Tax | 3364.00 | 4749.00 | 6066.00 | 7211.00 | 4969.00 | 4354.00 | 1937.00 | 570.75 | 157.91 | 66.35 | 8.39 | 14.05 | 17.05 | 13.08 | 16.02 | 35.42 | 41.76 | 28.85 | 29.04 | 91.90 | 42.47 | 41.12 | 30.33 | |
Revenues | 3364.00 | 4749.00 | 6066.00 | 7211.00 | 4969.00 | 4354.00 | 1937.00 | 570.75 | 157.91 | 66.35 | 8.39 | 14.05 | 17.05 | 13.08 | 16.02 | 35.42 | 41.76 | 28.85 | 29.04 | 91.90 | 42.47 | 41.12 | 30.33 | |
Cost Of Goods And Services Sold | 1100.00 | 1381.00 | 1017.00 | 952.00 | 722.00 | 750.00 | 193.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Costs And Expenses | 2198.00 | 2302.00 | 1839.00 | 1801.00 | 1411.00 | 1292.00 | 671.00 | 846.54 | 392.00 | 189.00 | 139.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Research And Development Expense | 820.00 | 710.00 | 554.00 | 648.00 | 521.00 | 421.00 | 401.00 | 758.86 | 344.49 | 151.86 | 115.14 | 117.52 | 119.72 | 128.50 | 130.57 | 150.43 | 109.05 | 104.48 | 90.12 | NA | NA | NA | NA | |
General And Administrative Expense | 278.00 | 211.00 | 268.00 | 201.00 | 168.00 | 121.00 | 77.00 | 78.99 | 48.54 | 36.62 | 24.11 | 25.63 | 28.19 | 28.52 | 27.28 | 38.02 | 18.52 | 21.39 | 16.32 | NA | NA | NA | NA | |
Operating Income Loss | 1166.00 | 2447.00 | 4227.00 | 5410.00 | 3558.00 | 3062.00 | 1266.00 | -275.04 | -235.12 | -122.13 | -130.86 | -130.56 | -130.86 | -143.94 | -141.83 | -153.03 | -85.82 | -97.02 | -77.40 | -41.83 | -67.87 | -94.19 | -65.46 | |
Allocated Share Based Compensation Expense | 70.00 | 50.00 | 44.00 | 37.00 | 40.00 | 35.00 | 30.00 | 25.48 | 23.21 | 23.92 | 20.41 | 20.33 | 20.80 | 21.50 | 18.50 | 31.64 | 14.72 | 14.35 | 11.85 | NA | NA | NA | NA | |
Income Tax Expense Benefit | 174.00 | 277.00 | 572.00 | 542.00 | 219.00 | 283.00 | 39.00 | 1.47 | 0.86 | 0.15 | 0.07 | -0.17 | -0.18 | -0.32 | -0.02 | 0.17 | 0.00 | 0.16 | 0.00 | NA | NA | NA | NA | |
Net Income Loss | 1043.00 | 2197.00 | 3657.00 | 4868.00 | 3333.00 | 2780.00 | 1221.00 | -272.49 | -233.64 | -116.71 | -124.23 | -123.12 | -123.19 | -135.05 | -132.66 | -141.43 | -80.33 | -90.60 | -72.38 | NA | NA | NA | NA | |
Comprehensive Income Net Of Tax | 932.00 | 2141.00 | 3497.00 | 4813.00 | 3348.00 | 2795.00 | 1219.00 | -274.26 | -237.11 | -102.33 | -132.16 | -124.14 | -123.11 | -132.90 | -130.75 | -141.82 | -79.24 | -89.46 | -74.37 | NA | NA | NA | NA |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | 26056.00 | 26043.00 | 27609.00 | 24669.00 | 20923.00 | 16153.00 | 12694.00 | 7336.75 | 4650.87 | 3486.01 | 2067.54 | 1589.42 | 1590.90 | 1685.28 | 1806.21 | 1962.15 | NA | NA | NA | 1084.49 | NA | NA | NA | |
Liabilities | 8064.00 | 8058.00 | 10534.00 | 10524.00 | 10799.00 | 9449.00 | 8856.00 | 4775.38 | 1891.08 | 539.12 | 426.67 | 414.61 | 339.09 | 346.73 | 360.17 | 431.91 | NA | NA | NA | 459.19 | NA | NA | NA | |
Liabilities And Stockholders Equity | 26056.00 | 26043.00 | 27609.00 | 24669.00 | 20923.00 | 16153.00 | 12694.00 | 7336.75 | 4650.87 | 3486.01 | 2067.54 | 1589.42 | 1590.90 | 1685.28 | 1806.21 | 1962.15 | NA | NA | NA | 1084.49 | NA | NA | NA | |
Stockholders Equity | 17992.00 | 17985.00 | 17075.00 | 14145.00 | 10124.00 | 6704.00 | 3838.00 | 2561.38 | 2759.80 | 2946.89 | 1640.87 | 1174.81 | 1251.81 | 1338.55 | 1446.03 | 1530.24 | -757.13 | -688.77 | -613.71 | -551.37 | NA | NA | NA |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | 14297.00 | 13563.00 | 16350.00 | 16071.00 | 13425.00 | 10969.00 | 11703.00 | 6297.88 | 3577.21 | 2796.74 | 1249.94 | 1128.80 | 1094.47 | 1097.42 | 1140.83 | 1563.01 | NA | NA | NA | 783.22 | NA | NA | NA | |
Cash And Cash Equivalents At Carrying Value | 3027.00 | 2873.00 | 5048.00 | 6848.00 | 5550.00 | 5603.00 | 5442.00 | 2623.85 | 1505.58 | 1761.63 | 391.72 | 235.88 | 173.71 | 151.62 | 502.93 | 658.36 | 167.06 | 140.62 | 90.48 | 134.86 | NA | NA | NA | |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 3041.00 | 2885.00 | 5060.00 | 6860.00 | 5561.00 | 5614.00 | 5453.00 | 2635.93 | 1517.67 | 1773.45 | 403.54 | 247.70 | 185.53 | 163.45 | 514.76 | 670.49 | 179.42 | 152.98 | 102.51 | 147.61 | NA | NA | NA | |
Accounts Receivable Net Current | 2695.00 | 2691.00 | 3173.00 | 3175.00 | 3142.00 | 2020.00 | 3210.00 | 1390.56 | 190.50 | 33.36 | 5.62 | 5.03 | 2.80 | 3.50 | 5.65 | 11.69 | NA | NA | NA | 11.88 | NA | NA | NA | |
Inventory Net | 2077.00 | 1921.00 | 1942.00 | 1441.00 | 965.00 | 643.00 | 494.00 | 46.53 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Other Assets Current | 85.00 | 76.00 | 36.00 | 55.00 | 43.00 | 38.00 | NA | 21.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Prepaid Expense And Other Assets Current | 1177.00 | 1054.00 | 1120.00 | 728.00 | 412.00 | 316.00 | 264.00 | 252.15 | 109.38 | 45.34 | 23.90 | 19.40 | 26.68 | 22.49 | 25.29 | 28.40 | NA | NA | NA | 12.83 | NA | NA | NA |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Assets Noncurrent | 38.00 | 75.00 | 82.00 | 34.00 | 4.00 | 2.00 | 1.00 | 1.88 | 2.05 | 1.57 | 1.74 | 1.93 | 2.09 | 2.56 | 2.44 | 2.64 | NA | NA | NA | 4.59 | NA | NA | NA |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liabilities Current | 6807.00 | 6812.00 | 9238.00 | 9128.00 | 9957.00 | 8840.00 | 8441.00 | 4388.81 | 1473.56 | 161.65 | 134.58 | 143.12 | 147.84 | 161.99 | 159.16 | 222.80 | NA | NA | NA | 191.46 | NA | NA | NA | |
Accounts Payable Current | 330.00 | 181.00 | 199.00 | 302.00 | 87.00 | 77.00 | 8.00 | 18.36 | 20.52 | 18.82 | 11.03 | 7.09 | 11.74 | 29.61 | 38.51 | 31.21 | NA | NA | NA | 20.73 | NA | NA | NA | |
Other Accrued Liabilities Current | 130.00 | 102.00 | 116.00 | 119.00 | 88.00 | 39.00 | NA | 25.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Taxes Payable Current | 66.00 | 349.00 | 1592.00 | 876.00 | 565.00 | 377.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Accrued Liabilities Current | 1856.00 | 1780.00 | 1608.00 | 1472.00 | 1076.00 | 848.00 | 753.00 | 469.59 | 208.83 | 89.20 | 55.02 | 67.65 | 60.08 | 44.59 | 42.18 | 79.07 | NA | NA | NA | 72.72 | NA | NA | NA | |
Other Liabilities Current | 553.00 | 409.00 | 240.00 | 225.00 | 252.00 | 613.00 | 149.00 | 33.66 | 9.70 | 8.38 | 9.69 | 5.06 | 5.83 | 4.39 | 4.51 | 3.46 | NA | NA | NA | 1.28 | NA | NA | NA | |
Contract With Customer Liability Current | 4002.00 | 4093.00 | 5599.00 | 6253.00 | 7977.00 | 7302.00 | 7531.00 | 3867.19 | 1234.51 | 45.24 | 58.84 | 63.31 | 70.19 | 83.40 | 73.96 | 109.06 | NA | NA | NA | NA | NA | NA | NA |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Liabilities Noncurrent | 81.00 | 113.00 | 91.00 | 76.00 | 1.00 | 1.00 | 2.00 | 1.85 | 2.18 | 1.22 | 1.25 | 0.14 | 0.16 | 0.19 | 0.21 | 0.26 | NA | NA | NA | 1.53 | NA | NA | NA | |
Operating Lease Liability Noncurrent | 79.00 | 87.00 | 95.00 | 106.00 | 105.00 | 105.00 | 96.00 | 97.42 | 98.95 | 99.64 | 108.92 | 93.67 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stockholders Equity | 17992.00 | 17985.00 | 17075.00 | 14145.00 | 10124.00 | 6704.00 | 3838.00 | 2561.38 | 2759.80 | 2946.89 | 1640.87 | 1174.81 | 1251.81 | 1338.55 | 1446.03 | 1530.24 | -757.13 | -688.77 | -613.71 | -551.37 | NA | NA | NA | |
Additional Paid In Capital | 1488.00 | 2413.00 | 3644.00 | 4211.00 | 5003.00 | 4931.00 | 4860.00 | 4801.85 | 4726.01 | 4675.99 | 3267.65 | 2669.43 | 2618.49 | 2582.13 | 2556.71 | 2538.16 | NA | NA | NA | 71.68 | NA | NA | NA | |
Retained Earnings Accumulated Deficit | 16855.00 | 15812.00 | 13615.00 | 9958.00 | 5090.00 | 1757.00 | -1023.00 | -2243.52 | -1971.03 | -1737.40 | -1620.68 | -1500.00 | -1369.55 | -1246.35 | -1111.30 | -1006.63 | NA | NA | NA | -621.89 | NA | NA | NA | |
Accumulated Other Comprehensive Income Loss Net Of Tax | -351.00 | -240.00 | -184.00 | -24.00 | 31.00 | 16.00 | 1.00 | 3.00 | 4.78 | 8.26 | -6.13 | 1.80 | 2.83 | 2.74 | 0.59 | -1.32 | NA | NA | NA | -1.16 | NA | NA | NA | |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 70.00 | 50.00 | 44.00 | 37.00 | 40.00 | 35.00 | 30.00 | 25.48 | 23.21 | 23.92 | 20.41 | 20.33 | 20.80 | 21.50 | 18.50 | 31.64 | 14.72 | 14.35 | 11.85 | NA | NA | NA | NA |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | 252.00 | 304.00 | 2763.00 | 3310.00 | 3276.00 | 4063.00 | 2971.00 | 1264.29 | 892.75 | -23.88 | -106.19 | -95.77 | -107.05 | -112.22 | -143.93 | -91.02 | -80.21 | -48.25 | -111.39 | NA | NA | NA | NA | |
Net Cash Provided By Used In Investing Activities | 945.00 | -1152.00 | -3921.00 | -1138.00 | -3327.00 | -3878.00 | -180.00 | -190.13 | -1178.26 | 12.48 | -316.02 | 130.35 | 113.37 | -246.90 | -11.76 | 6.79 | 116.08 | -11.64 | -483.70 | NA | NA | NA | NA | |
Net Cash Provided By Used In Financing Activities | -1041.00 | -1327.00 | -642.00 | NA | NA | -24.00 | 26.00 | 44.11 | 29.73 | 1381.31 | 578.05 | 27.59 | 15.77 | 7.81 | -0.05 | 575.91 | -9.43 | 110.36 | 550.00 | NA | NA | NA | NA |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | 252.00 | 304.00 | 2763.00 | 3310.00 | 3276.00 | 4063.00 | 2971.00 | 1264.29 | 892.75 | -23.88 | -106.19 | -95.77 | -107.05 | -112.22 | -143.93 | -91.02 | -80.21 | -48.25 | -111.39 | NA | NA | NA | NA | |
Net Income Loss | 1043.00 | 2197.00 | 3657.00 | 4868.00 | 3333.00 | 2780.00 | 1221.00 | -272.49 | -233.64 | -116.71 | -124.23 | -123.12 | -123.19 | -135.05 | -132.66 | -141.43 | -80.33 | -90.60 | -72.38 | NA | NA | NA | NA | |
Depreciation Depletion And Amortization | 113.00 | 76.00 | 79.00 | 78.00 | 70.00 | 69.00 | 15.00 | 7.71 | 8.50 | 7.60 | 7.45 | 8.90 | 7.30 | 7.50 | 7.30 | 7.39 | 6.50 | 5.90 | 5.15 | NA | NA | NA | NA | |
Increase Decrease In Accounts Receivable | 4.00 | -483.00 | -1.00 | 33.00 | 1122.00 | -1190.00 | 1819.00 | 1200.06 | 157.14 | 27.41 | 0.58 | 2.23 | -0.70 | -2.15 | -6.04 | 1.84 | -1.55 | 3.39 | -3.88 | NA | NA | NA | NA | |
Increase Decrease In Inventories | 156.00 | -21.00 | 501.00 | 476.00 | 322.00 | 148.00 | 448.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Increase Decrease In Accounts Payable | 145.00 | -21.00 | -35.00 | 178.00 | -18.00 | 59.00 | -15.00 | -1.76 | 2.16 | 9.14 | 2.33 | -4.78 | -17.71 | -3.20 | 1.73 | 14.30 | 2.06 | -2.81 | 1.47 | NA | NA | NA | NA | |
Deferred Income Tax Expense Benefit | -97.00 | -230.00 | -146.00 | -207.00 | -17.00 | -22.00 | -50.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Share Based Compensation | 70.00 | 50.00 | 44.00 | 37.00 | 40.00 | 35.00 | 30.00 | 25.48 | 23.21 | 23.92 | 20.41 | 20.33 | 20.80 | 21.50 | 18.50 | 31.64 | 14.72 | 14.35 | 11.85 | NA | NA | NA | NA |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Investing Activities | 945.00 | -1152.00 | -3921.00 | -1138.00 | -3327.00 | -3878.00 | -180.00 | -190.13 | -1178.26 | 12.48 | -316.02 | 130.35 | 113.37 | -246.90 | -11.76 | 6.79 | 116.08 | -11.64 | -483.70 | NA | NA | NA | NA | |
Payments To Acquire Property Plant And Equipment | 89.00 | 87.00 | 132.00 | 120.00 | 99.00 | 30.00 | 35.00 | 23.30 | 19.29 | 18.63 | 6.22 | 6.66 | 6.71 | 10.59 | 7.59 | 13.64 | 26.14 | 34.08 | 31.91 | NA | NA | NA | NA |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Financing Activities | -1041.00 | -1327.00 | -642.00 | NA | NA | -24.00 | 26.00 | 44.11 | 29.73 | 1381.31 | 578.05 | 27.59 | 15.77 | 7.81 | -0.05 | 575.91 | -9.43 | 110.36 | 550.00 | NA | NA | NA | NA | |
Payments For Repurchase Of Common Stock | 1006.00 | 1298.00 | 623.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 3364.00 | 4749.00 | 6066.00 | 7211.00 | 4969.00 | 4354.00 | 1937.00 | 570.75 | 157.91 | 66.35 | 8.39 | 14.05 | 17.05 | 13.08 | 16.02 | 35.42 | 41.76 | 28.85 | 29.04 | 91.90 | 42.47 | 41.12 | 30.33 | |
Biomedical Advanced Research And Development Authority, Grant | 141.00 | 179.00 | 122.00 | 259.00 | 128.00 | 134.00 | 192.00 | 338.52 | 143.32 | 37.05 | 3.00 | 3.10 | 1.14 | 1.88 | 1.50 | 2.20 | 2.00 | 1.60 | 1.00 | NA | NA | NA | NA | |
Other Grant Revenue, Grant | 3.00 | 4.00 | 4.00 | 3.00 | 12.00 | 5.00 | 2.00 | 2.85 | 2.38 | 0.86 | 1.00 | 0.39 | 2.57 | 1.18 | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Collaboration Arrangement | 100.00 | 35.00 | 15.00 | 14.00 | 19.00 | 18.00 | 10.00 | 29.50 | 12.22 | 28.44 | 3.19 | 10.05 | 9.61 | 9.84 | 13.30 | 19.99 | 16.93 | 19.74 | 20.11 | NA | NA | NA | NA | |
Product Sales | 3120.00 | 4531.00 | 5925.00 | 6935.00 | 4810.00 | 4197.00 | 1733.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Grant | 144.00 | 183.00 | 126.00 | 262.00 | 140.00 | 139.00 | 194.00 | 341.37 | 145.69 | 37.91 | 3.93 | 3.50 | 3.71 | 3.05 | 1.91 | 2.60 | 5.09 | 3.02 | 1.58 | NA | NA | NA | NA | |
Product Sales, | 1045.00 | 1390.00 | 2076.00 | 3806.00 | 1688.00 | 1056.00 | 284.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Product Sales,US | 985.00 | 1450.00 | 945.00 | 745.00 | 1197.00 | 2093.00 | 1358.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Product Sales, Rest Of The World | 1090.00 | 1691.00 | 2904.00 | NA | 1925.00 | 1048.00 | 91.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Revenue From Contract With Customer Excluding Assessed Tax | 3364.00 | 4749.00 | 6066.00 | 7211.00 | 4969.00 | 4354.00 | 1937.00 | 570.75 | 157.91 | 66.35 | 8.39 | 14.05 | 17.05 | 13.08 | 16.02 | 35.42 | 41.76 | 28.85 | 29.04 | 91.90 | 42.47 | 41.12 | 30.33 | |
Astra Zeneca, Collaboration Arrangement Including Arrangements With Affiliate | 76.00 | 4.00 | NA | 0.00 | 3.00 | 4.00 | NA | 15.42 | 0.05 | 16.00 | 1.00 | 0.51 | 3.72 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Merck, Collaboration Arrangement Including Arrangements With Affiliate | 20.00 | 5.00 | 10.00 | 12.00 | 7.00 | 4.00 | NA | 8.02 | 6.72 | 11.00 | 1.00 | 8.15 | 9.11 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Other Collaborative Parties, Collaboration Arrangement Including Arrangements With Affiliate | 0.00 | 1.00 | 1.00 | NA | 4.00 | 1.00 | 1.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Vertex, Collaboration Arrangement Including Arrangements With Affiliate | 4.00 | 25.00 | 4.00 | 3.00 | 5.00 | 9.00 | 9.00 | 5.81 | 5.45 | 2.00 | 2.00 | 1.89 | 0.50 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
Collaboration Arrangement Including Arrangements With Affiliate | 100.00 | 35.00 | 15.00 | 14.00 | 19.00 | 18.00 | 10.00 | 29.50 | 12.22 | 29.00 | 4.00 | 10.55 | 13.34 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |